Table 2. The majority of metastatic non-small cell lung cancers are RHAMM-positive.
| ID | RHAMM | Type | Metastatic site |
|---|---|---|---|
| 922 | + | Adenocarcinoma | Bone |
| 927 | + | Adenocarcinoma | Brain |
| 928 | + | NSCLC, NOS | Brain |
| 929 | − | Adenocarcinoma | Brain |
| 930 | + | NSCLC, NOS | Brain |
| 931 | + | NSCLC, NOS | Bone |
| 932 | + | Adenocarcinoma | Brain |
| 934 | + | NSCLC, NOS | Brain |
| 935 | + | Squamous cell carcinoma | Brain |
| 939 | + | Adenocarcinoma | Brain |
| 940 | + | Adenocarcinoma | Brain |
| 947 | + | Adenocarcinoma | Brain |
| 949 | + | Squamous cell carcinoma | Brain |
| 951 | + | Adenocarcinoma | Brain |
| 954 | + | Adenocarcinoma | Brain |
| 956 | + | Adenocarcinoma | Brain |
| 963 | + | Adenocarcinoma | Brain |
| 964 | + | Adenocarcinoma | Brain |
| 965 | + | Adenocarcinoma | Brain |
| 966 | + | Adenocarcinoma | Brain |
| 968 | + | Adenocarcinoma | Brain |
| 969 | + | Adenocarcinoma | Brain |
| 970 | + | Adenocarcinoma | Bone |
NOS: not otherwise specified.